Shanghai Pharmaceuticals (02607) Announces Updated Board of Directors and Committee Roles

Bulletin Express02-11 18:04

On February 11, 2026, Shanghai Pharmaceuticals Holding Co., Ltd. (Stock Code: 02607) released an updated roster of its board of directors. The board is composed of four executive directors—Chairman of the Board, YANG Qiuhua, along with SHEN Bo, LI Yongzhong, and DONG Ming—one non-executive director, ZHANG Wenxue, and one employee director, ZHAO Yong. Additionally, four independent non-executive directors—GU Zhaoyang, FOK Manson, WANG Zhong, and MAN Kwan—have been appointed.

The announcement also detailed committee memberships. The Strategy Committee is led by YANG Qiuhua, with participation from ZHANG Wenxue and WANG Zhong. The Nomination Committee is convened by FOK Manson, joined by SHEN Bo, GU Zhaoyang, and MAN Kwan. The Audit Committee is overseen by GU Zhaoyang, with committee members FOK Manson and WANG Zhong. Lastly, the Remuneration and Assessment Committee is headed by WANG Zhong, with involvement from YANG Qiuhua and GU Zhaoyang. This update was issued in Shanghai, the PRC, on February 11, 2026.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment